A 21st Century Evil: Immunopathology and New Therapies of COVID-19

Area of Science:

• Immunology
• Virology
• Infectious Diseases

Background:

• Coronavirus Disease 2019 (COVID-19), caused by SARS-CoV-2, is a global health crisis.
• The virus primarily affects the respiratory tract, utilizing the ACE2 receptor and impacting multiple organs.
• Severe cases involve significant immune system dysregulation, including lymphopenia and cytokine storms.

Purpose of the Study:

• To review the intricate interactions between SARS-CoV-2 and the human immune system.
• To elucidate the key immunopathological mechanisms driving COVID-19 severity.
• To discuss emerging therapeutic strategies, including drug repurposing and immunotherapy.

Main Methods:

• Literature review of studies on SARS-CoV-2 infection and host immune response.
• Analysis of immunopathological findings in COVID-19 patients.
• Synthesis of current research on potential therapeutic interventions.

Main Results:

• SARS-CoV-2 infection triggers profound immune alterations, characterized by lymphocyte dysfunction and excessive inflammation.
• Immunopathological mechanisms, such as cytokine storms, significantly contribute to disease severity and mortality.
• Existing treatments are limited, highlighting the need for novel therapeutic approaches.

Conclusions:

• Understanding the complex interplay between SARS-CoV-2 and the immune system is crucial for developing effective treatments.
• Targeting specific immune pathways and exploring immunotherapy show promise for managing COVID-19.
• Further research into immunomodulatory therapies is essential to combat this global threat.